MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
批准号:
6273965
负责人:
EDWARD L PRITCHETT
金额:
$2.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30
中文摘要
临床药理学和心脏病学部门的研究者,
杜克大学医学中心使用了兰金临床研究单位
研究患有房颤和其他常见疾病的患者,
心律心房颤动是最常见的疾病,
需要抗心律失常药物治疗的心律失常,
占美国所有心律失常住院治疗的三分之一以上。
房颤患者的心律通常正常
取而代之的是一段时间的快速,不规则的心跳,这可能会导致
感觉到胸部的撞击,呼吸急促,胸痛,
头晕或意识丧失。这些时间段可能持续几分钟,
小时,或者他们可能会无限期地持续下去,除非急性治疗是由
医生。
在兰金临床研究单位进行的研究集中在
在阐明机制,临床过程,和最佳治疗,
心房颤动和相关的心律失常。最近
研究集中于测量自发发生的频率
心房颤动和阵发性室上性心动过速之间
研究了150名停用抗抑郁药物治疗的患者,
一半患者在约3周内出现自发性症状复发;
事实上,大约五分之一的人有心律失常的症状复发,
少于1天。复发时平均心率为132
房颤患者为198次/min,
阵发性室上性心动过速患者。 患者中
在房颤患者中,约1/9的人有二次心律失常,房性心律失常,
扑动,记录沿着颤动。 无症状性心律失常
共同无症状性心律失常事件的发生率是对照组的12倍。
症状性事件的发生率。
英文摘要
Investigators in the Divisions of Clinical Pharmacology and Cardiology at
Duke University Medical Center have used the Rankin Clinical Research Unit
to study patients with atrial fibrillation and other common disorders of
the heart rhythm. Atrial fibrillation is the most common disorder of the
heart rhythm requiring treatment with antiarrhythmic drugs, and it
accounts for over one-third of all U.S. hospitalizations for arrhythmias.
Patients with atrial fibrillation have their usually normal heart rhythm
replaced by periods of rapid, irregular heart beating that may cause a
sense of pounding in the chest, shortness of breath, chest pain,
dizzyness, or loss of conciousness. These periods may last for minutes or
hours, or they may last indefinitely unless acute treatment is given by a
physician.
Studies conducted on the Rankin Clinical Research Unit have concentrated
on elucidating the mechanism, clinical course, and optimal treatment of
atrial fibrillation and related disorders of the heart rhythm. Recent
studies have focused on measuring the frequency of spontaneous occurrence
of atrial fibrillation and paroxysmal supraventricular tachycardia. Among
150 patients studied who had their antiarrhythmic drug therapy withdrawn,
one-half had a spontaneous, symptomatic recurrence in about 3 weeks; in
fact, about 1 in 5 had a symptomatic recurrence of their arrhythmia in
less than 1 day. The average heart rate during recurrences was 132
beats/min for patients with atrial fibrillation and 198 beats/min for
patients with paroxysmal supraventricular tachycardia. Among the patients
with atrial fibrillation, about 1 in 9 had a second arrhythmia, atrial
flutter, recorded along with fibrillation. Asymptomatic arrhythmias were
common. The rate of asymptomatic arrhythmia events was 12 fold higher than
the rate of symptomatic events.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
-
批准号:6565344
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2001
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6565362
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2001
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6565324
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2001
-
负责人:EDWARD L PRITCHETT
-
依托单位:
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
-
批准号:6463047
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6503064
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6415303
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
-
批准号:6415285
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
-
批准号:6503084
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6463065
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6503102
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6415265
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6463027
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6112786
-
项目类别:
-
资助金额:$4.09万
-
财政年份:1998
-
负责人:EDWARD L PRITCHETT
-
依托单位:
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
-
批准号:6112731
-
项目类别:
-
资助金额:$4.09万
-
财政年份:1998
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6112757
-
项目类别:
-
资助金额:$4.09万
-
财政年份:1998
-
负责人:EDWARD L PRITCHETT
-
依托单位:
PLACEBO CONTROLLED TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6273990
-
项目类别:
-
资助金额:$2.88万
-
财政年份:1997
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6274020
-
项目类别:
-
资助金额:$2.88万
-
财政年份:1997
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6273991
-
项目类别:
-
资助金额:$2.88万
-
财政年份:1997
-
负责人:EDWARD L PRITCHETT
-
依托单位:
TECH. SUPPORT/NIEHS CLINICAL RESEARCH PROGRAM
-
批准号:2309310
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:EDWARD L PRITCHETT
-
依托单位:
TECH. SUPPORT/NIEHS CLINICAL RESEARCH PROGRAM
-
批准号:6042908
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:EDWARD L PRITCHETT
-
依托单位:
海外基金